Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FDG Whole-Body PET/MRI in Oncology: a Systematic Review.

Literature DB >> 28250855

FDG Whole-Body PET/MRI in Oncology: a Systematic Review.

Hyun Woo Kwon¹, Ann-Katharina Becker², Jin Mo Goo³, Gi Jeong Cheon⁴.

Abstract

The recent advance in hybrid imaging techniques enables offering simultaneous positron emission tomography (PET)/magnetic resonance imaging (MRI) in various clinical fields. 18F-fluorodeoxyglucose (FDG) PET has been widely used for diagnosis and evaluation of oncologic patients. The growing evidence from research and clinical experiences demonstrated that PET/MRI with FDG can provide comparable or superior diagnostic performance more than conventional radiological imaging such as computed tomography (CT), MRI or PET/CT in various cancers. Combined analysis using structural information and functional/molecular information of tumors can draw additional diagnostic information based on PET/MRI. Further studies including determination of the diagnostic efficacy, optimizing the examination protocol, and analysis of the hybrid imaging results is necessary for extending the FDG PET/MRI application in clinical oncology.

Entities: Chemical Disease Species

Keywords: FDG; Oncology; PET/MRI; Positron emission tomography/magnetic resonance imaging

Year: 2016 PMID： 28250855 PMCID： PMC5313459 DOI： 10.1007/s13139-016-0411-3

Source DB: PubMed Journal: Nucl Med Mol Imaging ISSN： 1869-3474

98 in total

1. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.

Authors: Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; David Moher; Drummond Rennie; Henrica C W de Vet; Jeroen G Lijmer
Journal: Ann Intern Med Date: 2003-01-07 Impact factor: 25.391

2. Different patterns of duplicate publication: an analysis of articles used in systematic reviews.

Authors: Erik von Elm; Greta Poglia; Bernhard Walder; Martin R Tramèr
Journal: JAMA Date: 2004-02-25 Impact factor: 56.272

3. Thoracic staging of non-small-cell lung cancer using integrated (18)F-FDG PET/MR imaging: diagnostic value of different MR sequences.

Authors: Benedikt Schaarschmidt; Christian Buchbender; Benedikt Gomez; Christian Rubbert; Florian Hild; Jens Köhler; Johannes Grueneisen; Henning Reis; Verena Ruhlmann; Axel Wetter; Harald H Quick; Gerald Antoch; Philipp Heusch
Journal: Eur J Nucl Med Mol Imaging Date: 2015-04-08 Impact factor: 9.236

4. N staging of lung cancer patients with PET/MRI using a three-segment model attenuation correction algorithm: initial experience.

Authors: A A Kohan; J A Kolthammer; J L Vercher-Conejero; C Rubbert; S Partovi; R Jones; K A Herrmann; P Faulhaber
Journal: Eur Radiol Date: 2013-06-14 Impact factor: 5.315

5. Initial Experience of 18F-FDG PET/MRI in Thymic Epithelial Tumors: Morphologic, Functional, and Metabolic Biomarkers.

Authors: Geewon Lee; Hoseok I; Seong-Jang Kim; Kyoungjune Pak; Jeong Su Cho; Yeon Joo Jeong; Chang Hun Lee; Samuel Chang
Journal: Clin Nucl Med Date: 2016-01 Impact factor: 7.794

6. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.

Authors: Gi Jeong Cheon; Min Suk Kim; Jun Ah Lee; Soo-Yong Lee; Wan Hyeong Cho; Won Seok Song; Jae-Soo Koh; Ji Young Yoo; Dong Hyun Oh; Duk Seop Shin; Dae-Geun Jeon
Journal: J Nucl Med Date: 2009-08-18 Impact factor: 10.057

7. Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series.

Authors: C Brendle; N F Schwenzer; H Rempp; H Schmidt; C Pfannenberg; C la Fougère; K Nikolaou; C Schraml
Journal: Eur J Nucl Med Mol Imaging Date: 2015-07-31 Impact factor: 9.236

8. ¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma.

Authors: Chang-Bae Kong; Byung Hyun Byun; Ilhan Lim; Chang Woon Choi; Sang Moo Lim; Won Seok Song; Wan Hyeong Cho; Dae-Geun Jeon; Jae-Soo Koh; Ji Young Yoo; Soo-Yong Lee
Journal: Eur J Nucl Med Mol Imaging Date: 2013-01-30 Impact factor: 9.236

9. Pulmonary Nodule Detection in Patients with a Primary Malignancy Using Hybrid PET/MRI: Is There Value in Adding Contrast-Enhanced MR Imaging?

Authors: Kyung Hee Lee; Chang Min Park; Sang Min Lee; Jeong Min Lee; Jeong Yeon Cho; Jin Chul Paeng; Su Yeon Ahn; Jin Mo Goo
Journal: PLoS One Date: 2015-06-11 Impact factor: 3.240

FDG Whole-Body PET/MRI in Oncology: a Systematic Review.

1. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.

2. Different patterns of duplicate publication: an analysis of articles used in systematic reviews.

3. Thoracic staging of non-small-cell lung cancer using integrated (18)F-FDG PET/MR imaging: diagnostic value of different MR sequences.

4. N staging of lung cancer patients with PET/MRI using a three-segment model attenuation correction algorithm: initial experience.

5. Initial Experience of 18F-FDG PET/MRI in Thymic Epithelial Tumors: Morphologic, Functional, and Metabolic Biomarkers.

6. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.

7. Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series.

8. ¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma.

9. Pulmonary Nodule Detection in Patients with a Primary Malignancy Using Hybrid PET/MRI: Is There Value in Adding Contrast-Enhanced MR Imaging?

10. Does the novel integrated PET/MRI offer the same diagnostic performance as PET/CT for oncological indications?

1. The role of radiological and hybrid imaging for muscle metastases: a systematic review.

2. FPGA-Based Interface of Digital DAQ System for Double-Scattering Compton Camera.

3. Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience.

Review 4. Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools.